Agoracom: Small Cap Investment - Zenith Epigenetics - Interim Financial .... Interim MD&A .... Reporting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Interim Financial .... Interim MD&A .... Reporting

posted on Apr 05, 2024 05:49PM

On SEDAR & Zenith Epigenetics Home Site:

-Condensed Interim Consolidated Financial Statements For the three and nine months ended January 31, 2024 and 2023

-Interim Management’s Discussion & Analysis January 31, 2024

Koo

3 Recommendations

Re: Interim Financial .... Interim MD&A .... Reporting

fuzzyjr

Apr 07, 2024 04:23PM

Re: Interim Financial .... Interim MD&A .... Reporting

chicagoest

Apr 07, 2024 11:51PM

Re: Interim Financial .... Interim MD&A .... Reporting

fuzzyjr

Apr 08, 2024 08:14AM

Reply New Message

Back To Forum List View

Please to post a reply